Related Experiment Video
Updated: Aug 18, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats
Published on: February 20, 2019
Pharmacological treatments of pathological gambling
Eric Hollander1, Erica Sood, Stefano Pallanti
1Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, Box 1230, One Gustave L. Levy Place, New York, NY, USA. eric.Hollander@mssm.edu
Abstract:
Medication treatment studies have demonstrated short-term efficacy of various SRIs, opioid antagonists, and mood stabilizers in sub-samples of adult treatment seeking pathological gamblers. Pathological gambling is frequently comorbid with bipolar spectrum disorders, substance abuse/dependence, and attention-deficit/hyperactivity disorder (ADHD), and comorbidity may influence treatment response in pathological gambling. This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Psychosis: Goals of Pharmacotherapy
CNS Depressants: Alcohol and Nicotine
Alzheimer's Disease: Treatment
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Therapy
Antianxiety Medications

